Efficacy of Local Doxycycline Gel Delivery Versus Doxycycline Nanoparticles Prepared Gel in The Treatment of Stage II Periodontitis
1 other identifier
interventional
45
1 country
1
Brief Summary
To evaluate the Efficacy of Local Doxycycline Gel Delivery Versus Doxycycline Nanoparticles Prepared Gel in The Treatment of stage II Periodontitis Materials and methods: forty five patients (n=45) were selected from the Department of Oral Medicine and Periodontology, Faculty of Dentistry, Mansoura University. 45 particpants are classified into 3 groups Group 1(test group): 15 Patients will be treated with doxycycline gel (regular non-nanoparticle form) as an adjunct to mechanical debridement. Group 2 (test group): 15 Patients will be treated with doxycycline-loaded Poly lactic-co-glycolic acid (PLGA) nanoparticles gel as an adjunct to mechanical debridement. Group 3 (control group): 15 patients will be treated with mechanical debridement only. After proper examination and diagnosis, full mouth supra- and subgingival scaling and root planning will be performed over two weeks (two consecutive days per week) and all periodontitis patients will be treated with ultrasonic scaler and hand instrument for meticulous removal of subgingival and supragingival plaque and calculus. All patients will receive oral hygiene instructions. Gel Application: After completion of scaling and root planning the doxycycline gel will be injected subgingivally in the deepest selected periodontitis pockets of the group 1 and doxycycline-loaded Poly lactic-co-glycolic acid (PLGA) gel in group 2 using a disposable syringe. Care will be taken to apply the gel without traumatizing or damaging the periodontal tissues. Participants will be instructed to refrain from chewing hard or consuming sticky foods, brushing near the treated areas, or using any interdental aids for 1 week. The injection will be applied in the third week with maintenance of good oral hygiene. Periodontal Parameters: Changes in the clinical parameters will be evaluated. For all periodontitis patients, the Clinical assessment will be performed at baseline, after 4 weeks and after 8 weeks from the start of the study. All these clinical parameters will be assessed:
- 1.Plaque Index according to Silness \& Loe 1964.26
- 2.Gingival Bleeding Index according to Ainamo \& Bay 1975.27
- 3.Probing pocket depth (PPD) 28 is measured from free gingival margin to the base of the pocket.
- 4.Clinical attachment level (CAL) 29 is measured from the cement-enamel junction to the base of the pocket.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 2, 2024
CompletedFirst Submitted
Initial submission to the registry
May 20, 2025
CompletedFirst Posted
Study publicly available on registry
May 29, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2025
CompletedMay 29, 2025
August 1, 2024
1.2 years
May 20, 2025
May 20, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
probing pocket depth reduction
pocket depth is calculated using periodontal probe to calculate the distance between the base of the pocket to the free gingival margin
8 weeks
Secondary Outcomes (5)
plaque index
8 weeks
clinical attachment gain
8 weeks
gingival bleeding index
8 weeks
microbiological detection of p.gingivalis
8 weeks
microbiological detection for p.intermedia
8 weeks
Study Arms (3)
group 1: doxycycline gel+SRP
EXPERIMENTALdoxycycline gel (regular non-nanoparticle form) as an adjunct to mechanical debridement.
group 2: doxycycline-loaded(PLGA) nanoparticles gel +SRP
EXPERIMENTALdoxycycline-loaded Poly lactic-co-glycolic acid (PLGA) nanoparticles gel as an adjunct to mechanical debridement.
group 3: mechanical debridement only.
ACTIVE COMPARATORscaling and root planing alone
Interventions
doxycycline gel exhibits bacteriostatic activity against prevalent periodontal pathogens
Eligibility Criteria
You may qualify if:
- Patients of both sexes above 20 years old
- Patients with probing pocket depth ≤ 5 mm.
- No history of antibiotic and periodontal therapy in the last 3 months
You may not qualify if:
- Patients with systemic diseases.
- Pregnant and lactating females.
- Heavy smokers.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mansoura, Egypt, 35516
Al Mansurah, Dakahlia Governorate, 0000, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 20, 2025
First Posted
May 29, 2025
Study Start
June 2, 2024
Primary Completion
August 1, 2025
Study Completion
September 1, 2025
Last Updated
May 29, 2025
Record last verified: 2024-08